INSIGHTS

Clear perspectives.

Stronger strategies.

Timely insights, expert analysis, and industry intelligence to help MedTech teams make smarter commercial decisions.

Browse Topics

Get insights in your inbox

Featured Insights

FEATURED

The Fellowship Effect: Why Nearly Every Orthopedic Surgeon Now Specializes — visual 2x — ClearSight Health

Match Day News

Jul 27, 2026

The Fellowship Effect: Why Nearly Every Orthopedic Surgeon Now Specializes

93% of graduating orthopedic residents now continue into fellowship. ClearSight mapped where the 2026 class is headed and the four subspecialties that dominate the pipeline.

Beyond the Heart: Why More Interventional Cardiologists Are Treating Peripheral Artery Disease

Interventional cardiology was built around the coronary arteries. ClearSight identified 1,625 interventional cardiologists now treating vascular disease far beyond the heart.

The Stone Wars: Why ESWL Isn’t Going Away

Ureteroscopy won the volume race, but ESWL never left. ClearSight analyzed activity at 2,433 ESWL facilities to see how kidney stone treatment really divided.

Latest Insights

Peripheral vascular care keeps shifting into office-based labs. A federal review signals the next phase will be judged on appropriateness, not growth.

Cardiology’s ASC Moment

CMS has opened ambulatory surgery centers to cardiac ablation and more cardiovascular work. The build-out, staffing and safety data decide who moves first.

The Rise of the Surgeon-Scientist Chair

Academic centers are choosing chairs who operate, run laboratories and recruit the next generation. That combination changes who influences device adoption.

Five Faculty Moves Reshaping Procedural Medicine in 2026

Five chair and division-chief appointments landed this quarter. Each one signals where an institution plans to build procedural capability next.

The Hospitals Winning the Class of 2026

Physicians often stay near where they train, but procedural specialists move for case mix and infrastructure. ClearSight tracked which hospitals recruited the 2026 class from outside their local pipelines.

Cardiology Is Highly Competitive. So Why Are Advanced Fellowships Going Unfilled?

Every cardiovascular disease position filled in 2026. Interventional cardiology filled 76.9% and advanced heart failure only 59.8%. ClearSight looks at why the advanced fellowships are going unfilled.

From Scalpel to Catheter: How Cardiothoracic Training Is Changing

TAVR reshaped the cardiac surgeon’s role, but training exposure varies widely. ClearSight connected 115 cardiothoracic programs to the TAVR volume of their faculty.

The Fellowship Effect: Why Nearly Every Orthopedic Surgeon Now Specializes

93% of graduating orthopedic residents now continue into fellowship. ClearSight mapped where the 2026 class is headed and the four subspecialties that dominate the pipeline.

Beyond the Heart: Why More Interventional Cardiologists Are Treating Peripheral Artery Disease

Interventional cardiology was built around the coronary arteries. ClearSight identified 1,625 interventional cardiologists now treating vascular disease far beyond the heart.

The Stone Wars: Why ESWL Isn’t Going Away

Ureteroscopy won the volume race, but ESWL never left. ClearSight analyzed activity at 2,433 ESWL facilities to see how kidney stone treatment really divided.

The Next Battleground in Orthopedics May Be the Shoulder

Shoulder arthroplasty, rotator cuff repair, and arthroscopy are all moving at once. ClearSight analyzed 2.2 million procedures to map where the momentum is concentrated.

The FFR Paradox: Why the Gold Standard Isn’t the Standard Everywhere

FFR is one of the most validated technologies in interventional cardiology, yet its use is anything but even. ClearSight analyzed 185,373 procedures to see who actually adopts it.

6 min read

Get the signal your commercial team is missing.

Book a demo and we'll show you what's inside the ClearSight graph.

BOOK A DEMO